The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer treatments, and that manufacturers might stop making products that become unprofitable as a result.
仿制藥行業(yè)警告稱，美國對藥品征收關(guān)稅可能導(dǎo)致包括癌癥治療在內(nèi)的藥品短缺，制造商可能會停止生產(chǎn)因此變得無利可圖的產(chǎn)品。
您已閱讀5%（282字），剩余95%（5569字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。